Rivera LR, Olaya VA, Velazco HL, Cárdenas CR, Galván DC, Ponce CJ, García VJ, Melchor VY

Language: English
References: 29
Page: 503-510
PDF size: 271.50 Kb.

ABSTRACT

Childhood cancer is the second cause of mortality of the population between 4 and 15 years. More than 20 million new cases of cancer in the world are expected by the year 2025, and 80% of the load will be on countries of low to middle income. In the past two decades, significant changes have been observed in patterns of incidence, prevalence, survival, and childhood cancer mortality in Mexico.
An extensive review of all the published studies in Mexico by various health institutions revealed a steady 18-year trend of 150 new cases/million/year. The prevalence showed that acute leukemias constitute a 50% of all childhood cancer cases, followed by lymphoma (Hodkin and non-Hodgkin), and primary malignant brain tumors. A significant survival rate was observed in 8 thousand children with acute lymphoblastic leukemia with an overall 5-year survival rate of 62%, with a range of 45 to 73%. The national mortality rate for all types of cancer was 5.2/100,000/year, which is higher than what is reported in most middle-income countries. In the face of the current results, the need arises to modify how we approach this group of diseases by integrating a socio-educational healthcare of the Mexican children who are currently treated under unfavorable conditions. The current sanitary authorities must be aware of the importance of the transmission and adjustment of the care received by children with these diseases at a national level, to be in line with international standards.

REFERENCES

1. Childhood Cancer. World Health Organization (WHO) 2021.https://www.who.int/initiatives/the-global-initiative-forchildhood-cancer (accessed May 14, 2024).

2. Bella S., Michael J., McNeil., Linh T.D, D Pham, Linh T,Yichen Chen et al. Treatment-Related Mortality in Childrenwith Cancer in Low- and Middle-Income Countries: A SystematicReview and Meta-Analysis. The Lancet Oncology.Volume 24, 9, 2023, 996-967

3. 977. https://doi.org/10.1016/S1470-2045(23)00318-2

4. Instituto Nacional de Estadística y Geografía (INEGI) https://www.inegi.org.mx/app/indicadores/?t=18&ag=31#D18(accessed April 29, 2024).

5. Registro de Cáncer de Niños y Adolescentes. DirecciónGeneral de Epidemiología. gob. mx. https://www.gob.mx/cms/uploads/attachment/file/632369/RNCA_2019.pdf (accessed January 12, 2024)

6. Monárrez-Espino J, Romero-Rodriguez L, Escamilla-AsiainG, Ellis-Irigoyen A, Cubría-Juárez MDP, Sematimba D, et al.Survival estimates of childhood malignancies treated at theMexican telethon pediatric oncology hospital. Cancer Rep(Hoboken). 2023 Feb;6(2):e1702. doi: 10.1002/cnr2.1702.Epub 2022 Aug 30. PMID: 36054813; PMCID: PMC9939997.

7. Centro Nacional para la Salud de la Infancia y Adolescencia.Programa de Cancer Infantil. https://www.gob.mx/salud/censia/acciones-y-programas/programa-cancer-en-lainfancia-y-la-adolescencia (accessed march 23, 2024)

8. World Bank. https://www.worldbank.org/en/country/mexico/overview, 2022. (accessed June 7, 2024)

9. Union for International Cancer Control. GLOBOCAN 17December 2020. New Global Cancer Data. https://www.uicc.org (accessed February 2, 2024).

10. Advancing the Development of National Childhood Cancer-Care Strategies in Latin America. Evidence Brief. Denburk A,Wilson MG, Gupta S, Kutluk T, Torode J. Merit Reviewers:Antillon KF, Rodriguez-Galindo C, Nunez C, Rivera-Luna R.McMaster Health Forum, McMaster University. 2015. ISSN1925-2242, e 1925-2250.

11. Seguro Popular. Fondo de gastos catastróficos en niños concancerhttps://www.gob.mx/salud/prensa/2018.

12. IMSS/Bienestar.https://ciep.mx/imss-bienestar-estimacion-del-impacto-presupuestario/2023

13. Maura O'Leary, Mark Krailo, James R Anderson, et al. Children'sOncology Group. Progress in childhood cancer: 50years of research collaboration, a report from the Children'sOncology Group. Semin Oncol. 2008 Oct;35(5):484-93.doi: 10.1053/j.seminoncol.2008.07.008. DOI: 10.1053/j.seminoncol.2008.07.008

14. Perfil epidemiológico del cáncer en niños y adolescentes.https://es.scribd.com/doc/238280102/Mexico-2011 (accessedJune 5, 2024)

15. Rivera-Luna R, Velasco-Hidalgo L, Zapata-Tarrés M, et al.Current outlook of childhood cancer epidemiology in amiddle-income country under a public health insuranceprogram. Pediatr Hematol Oncol. 2017 feb;34(1):43-50.

16. Siegel D, Li J, Henley J, Wilson RJ, Buchanan N; Tai E. et al.Geographic Variation in Pediatric Cancer Incidence-UnitedStates, 2003–2014. Weekly / June 29, 2018/67(25);707–713. https://www.cdc.gov/mmwr/volumes/67/wr/mm6725a2.htm/childhood%20cancer incidence. (accesadoen 2 junio 2024)

17. Juntos contra el cáncer infantil | Instituto Mexicano delSeguro Social. https://www.gob.mx/imss/articulos/juntoscontra-el-cancer-infantil 2023. (accessed May 12, 2024)

18. Gupta S, Rivera-Luna R, Ribeiro RC, Howard SC. Pediatriconcology as the next global child health priority: the needfor national childhood cancer strategies in low- and middleincomecountries. PLoS Med. 2014 Jun 17;11(6):e1001656.doi: 10.1371/journal.pmed.1001656. PMID: 24936984;PMCID: PMC4061014.

19. Knaul FM, Arreola-Ornelas H, Touchton M, McDonald T,Blofield M, Avila Burgos L, et al. Setbacks in the questfor universal health coverage in Mexico: polarizedpolitics, policy upheaval, and pandemic disruption.Lancet. 2023 Aug 26;402(10403):731-746. doi: 10.1016/S0140-6736(23)00777-8. Epub 2023 Aug 7. Erratum in:Lancet. 2023 Dec 2;402(10417):2076. doi: 10.1016/S0140-6736(23)02651-X. PMID: 37562419.

20. Malvezzi M, Santucci C, Aliandro G, Carioli G , Boffetta P,Braga K et al. Childhood cancer mortality in the Americasand Australasia; an update to 2017. Cancer 2021;127:3445-3456. Doi 10:1002/ener.33642.

21. Cerecero-García D, Macías-González F, Muñoz-Aguirre P,Huerta-Gutierrez R, Zapata M, Rivera-Luna R, et al. Impactof Fee For Service on the Efficiency and Survival of SeguroPopular's Patients With Acute Lymphoblastic Leukemiain Mexico. JCO Glob Oncol. 2024 May;10:e2300060. doi:10.1200/GO.23.00060. PMID: 38754053.

22. Rivera-Luna R, Galvan-Diaz C, Velazco-Hidalgo L. DemographicFactors that Impact the Prognosis of ChildhoodAcute Lymphoblastic Leukemia in a Middle-income country.European J Pediatric Oncology 2024 In press.

23. Rivera-Luna R, Perez-Vera P, Galvan-Diaz C, Velasco-HidalgoL, Olaya-Vargas A, Cardenas-Cardos R, et al. Triple-hitexplanation for the worse prognosis of pediatric acutelymphoblastic leukemia among Mexican and Hispanicchildren. Front Oncol. 2022 Nov 30;12:1072811. doi:10.3389/fonc.2022.1072811. PMID: 36531028; PMCID:PMC9747921.

24. Zapata-Tarrés M, Balandrán JC, Rivera-Luna R, PelayoR. Childhood Acute Leukemias in Developing Nations:Successes and Challenges. Curr Oncol Rep. 2021 Mar23;23(5):56. doi: 10.1007/s11912-021-01043-9. PMID:33755790.

25. Schraw JM, Peckham-Gregory EC, Hughes AE, ScheurerME, Pruitt SL, Lupo PJ. Residence in a Hispanic Enclave IsAssociated with Inferior Overall Survival among Childrenwith Acute Lymphoblastic Leukemia. Int J Environ ResPublic Health. 2021 Sep 2;18(17):9273. doi: 10.3390/ijerph18179273. PMID: 34501862; PMCID: PMC8430860.

26. Zapata-Tarrés M, Balandrán JC, Rivera-Luna R, Pelayo R.Childhood Acute Leukemias in Developing Nations: Successesand Challenges. Curr Oncol Rep. 2021 Mar 23;23(5):56.doi: 10.1007/s11912-021-01043-9. PMID: 33755790

27. Moreira DC, González-Ramella O, Echavarría Valenzuela M,Carrillo AK, Faughnan L, Job G, Chen Y, et al. Evaluation offactors leading to poor outcomes for pediatric acute lymphoblasticleukemia in Mexico: a multi-institutional reportof 2,116 patients. Front Oncol. 2023 Sep 18;13:1255555.doi: 10.3389/fonc.2023.1255555. PMID: 37790759; PMCID:PMC10544893.

28. Kehm RD, Spector LG, Poynter JN, Vock DM, Altekruse SF,Osypuk TL. Does socioeconomic status account for racialand ethnic disparities in childhood cancer survival? Cancer.2018 Oct 15;124(20):4090-4097. doi: 10.1002/cncr.31560.Epub 2018 Aug 20. PMID: 30125340; PMCID: PMC6234050.

29. Rivera-Luna R, Zapata-Tarres M, Shalkow-Klincovstein J,Velasco-Hidalgo L, Olaya-Vargas A, Finkelstein-Mizrahi N,et al. The burden of childhood cancer in Mexico: Implicationsfor low- and middle-income countries. Pediatr BloodCancer. 2017 Jun;64(6). doi: 10.1002/pbc.26366. Epub2016 Dec 1. PMID: 27905680..